4.5 Article

GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbamcr.2019.01.001

Keywords

GP73; TGF-beta signaling; Caveolae-1; ERK; HCC

Funding

  1. National Natural Science Foundation of China [31471325, 31670761, 31571424, 31470850, 81671973, 81773205]
  2. Beijing Nova Program [Z171100001117121]

Ask authors/readers for more resources

Increased GP73 expression in hepatocytes from patients with acute hepatitis, through disease progression to cirrhosis and chronic liver disease suggests that progressive tissue remodeling and fibrogenesis are driving forces for GP73 upregulation. Nevertheless, details about regulation of GP73 expression and its biological functions remain elusive and await further characterization. In this study, we demonstrate that GP73 is a direct target of TGF-beta 1 transcriptional regulation. Its induced expression inhibits TGF-beta-Smad mediated growth suppression. On the other hand, elevated GP73 results in upregulation of ERK/Akt signaling induced by TGF-beta 1. Mechanistically, upregulation of lipid raft and caveolae-1 induced by GP73 overexpression mediates its regulatory effect on TGF-beta 1 signaling. Notably, lipid raft expression is elevated in HCC tumors and tissues with higher GP73 expression yield more intensive Flotillin staining. Our results establish the linkage between GP73 and TGF-beta signaling, indicating that GP73 may promote HCC tumorigenesis by selectively regulating TGF-beta signaling through lipid raft modulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available